ID   GNE-587170
AC   CVCL_AT69
SY   OCI-Ly-3 Boston variant
DR   BioSample; SAMN03470848
DR   Wikidata; Q54871608
RX   PubMed=25877200;
WW   https://iclac.org/wp-content/uploads/Cross-Contaminations_v12_distribution.xlsx
CC   Problematic cell line: Misidentified. This cell line was mistakenly distributed by OCI to a number of groups as being OCI-Ly-3 (Cellosaurus=CVCL_8800). The real identity of this cell line is not known. From personal communication of Neve R.
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00517.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,13
ST   D16S539: 10
ST   D18S51: 18,19
ST   D21S11: 28,30
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 21,25
ST   Penta D: 2.2,8
ST   Penta E: 5,8
ST   TH01: 7
ST   TPOX: 6,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Undefined cell line type
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 8
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//